BRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatment
BRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatment
About this item
Full title
Author / Creator
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Summary
We report a patient with a metastatic relapse of clear cell sarcoma, whose tumor harbored
BRAF
V600E mutation. Standard chemotherapy with doxorubicin and ifosfamide failed to slow the disease progression. Subsequent administration of vemurafenib (960 mg twice a day) resulted in complete tumor response after 8 weeks of treatment. Li...
Alternative Titles
Full title
BRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatment
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1713529785
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1713529785
Other Identifiers
ISSN
0167-6997
E-ISSN
1573-0646
DOI
10.1007/s10637-015-0280-0
